Penumbra, Inc. (PEN) Financial Ratios
13 years of historical data (2013–2025) · Healthcare · Medical - Devices
EV/EBITDA
↓
60.51
↓-85% vs avg
5yr avg: 390.92
30Y Low59.3·High98.5
P/FCF
↓
71.32
↓-16% vs avg
5yr avg: 84.42
30Y Low63.3·High120.1
P/B Ratio
↓
8.73
-3% vs avg
5yr avg: 8.97
30Y Low3.3·High12.3
ROE
↑
13.8%
↓+190% vs avg
5yr avg: 4.8%
30Y Low-3%·High14%
Debt/EBITDA
↓
1.06
↓-86% vs avg
5yr avg: 7.48
30Y Low1.1·High19.5
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
PEN Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Penumbra, Inc. trades at 70.2x earnings, 90% below its 5-year average of 722.3x, sitting at the 25th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 217%. On a free-cash-flow basis, the stock trades at 71.3x P/FCF, 16% below the 5-year average of 84.4x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $12.5B | $12.2B | $9.3B | $9.9B | $8.4B | $10.9B | $6.3B | $6.0B | $4.4B | $3.3B | $2.1B |
| Enterprise Value | $12.5B | $12.2B | $9.2B | $9.9B | $8.6B | $11.0B | $6.3B | $6.0B | $4.3B | $3.3B | $2.1B |
| P/E Ratio → | 70.18 | 68.79 | 659.67 | 108.42 | — | 2052.29 | — | 122.59 | 678.89 | 723.85 | 145.00 |
| P/S Ratio | 8.89 | 8.70 | 7.81 | 9.32 | 9.94 | 14.56 | 11.17 | 10.88 | 9.91 | 9.96 | 8.11 |
| P/B Ratio | 8.73 | 8.56 | 8.10 | 8.37 | 8.43 | 11.41 | 9.81 | 12.27 | 10.44 | 8.30 | 8.01 |
| P/FCF | 71.32 | 69.83 | 63.31 | 120.12 | — | — | — | 1311.34 | 229.62 | — | — |
| P/OCF | 52.27 | 51.19 | 55.35 | 101.35 | — | 1145.45 | — | 223.53 | 153.08 | 261.88 | — |
P/E links to full P/E history page with 30-year chart
PEN EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Penumbra, Inc.'s enterprise value stands at 60.5x EBITDA, 85% below its 5-year average of 390.9x. The Healthcare sector median is 14.2x, placing the stock at a 326% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 8.73 | 7.72 | 9.38 | 10.13 | 14.71 | 11.18 | 10.90 | 9.76 | 9.81 | 8.06 |
| EV / EBITDA | 60.51 | 59.25 | 279.69 | 98.52 | 282.35 | 1234.78 | — | 107.30 | 816.77 | 661.72 | 2241.46 |
| EV / EBIT | 66.10 | 59.71 | 413.89 | 122.02 | 1521.75 | — | — | 125.60 | 144.81 | 2809.35 | — |
| EV / FCF | — | 70.02 | 62.62 | 120.94 | — | — | — | 1313.43 | 226.08 | — | — |
PEN Profitability
Margins and return-on-capital ratios measuring operating efficiency
Penumbra, Inc. earns an operating margin of 13.5%. Operating margins have expanded from 6.9% to 13.5% over the past 3 years, signaling improving operational efficiency. ROE of 13.8% is modest. ROIC of 11.3% represents solid returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.1% | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% | 60.3% | 68.0% | 65.7% | 65.1% | 64.9% |
| Operating Margin | 13.5% | 13.5% | 0.8% | 6.9% | 0.7% | -1.0% | -6.9% | 8.7% | -0.2% | 0.3% | -0.5% |
| Net Profit Margin | 12.7% | 12.7% | 1.2% | 8.6% | -0.2% | 0.7% | -2.8% | 8.9% | 1.5% | 1.4% | 5.6% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 13.8% | 13.8% | 1.2% | 8.4% | -0.2% | 0.7% | -2.8% | 10.7% | 1.6% | 1.4% | 5.9% |
| ROA | 10.6% | 10.6% | 0.9% | 6.2% | -0.2% | 0.5% | -2.1% | 8.2% | 1.3% | 1.2% | 5.2% |
| ROIC | 11.3% | 11.3% | 0.6% | 4.6% | 0.4% | -0.7% | -5.1% | 8.4% | -0.2% | 0.3% | -0.4% |
| ROCE | 12.5% | 12.5% | 0.7% | 5.6% | 0.5% | -0.8% | -6.0% | 9.3% | -0.2% | 0.3% | -0.5% |
PEN Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Penumbra, Inc. carries a Debt/EBITDA ratio of 1.1x, which is manageable (67% below the sector average of 3.2x). Net debt stands at $33M ($220M total debt minus $187M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.15 | 0.15 | 0.19 | 0.20 | 0.24 | 0.18 | 0.12 | 0.17 | — | — | — |
| Debt / EBITDA | 1.06 | 1.06 | 6.77 | 2.32 | 7.75 | 19.48 | — | 1.48 | — | — | — |
| Net Debt / Equity | — | 0.02 | -0.09 | 0.06 | 0.17 | 0.12 | 0.01 | 0.02 | -0.16 | -0.13 | -0.05 |
| Net Debt / EBITDA | 0.16 | 0.16 | -3.06 | 0.66 | 5.46 | 12.82 | — | 0.17 | -12.76 | -10.24 | -13.98 |
| Debt / FCF | — | 0.19 | -0.69 | 0.81 | — | — | — | 2.10 | -3.53 | — | — |
| Interest Coverage | — | — | 15.72 | 46.80 | 3.23 | -4.43 | — | — | — | — | — |
PEN Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Penumbra, Inc.'s current ratio of 6.64x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 4.29x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 6.06x to 6.64x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.64 | 6.64 | 6.01 | 6.06 | 5.21 | 5.53 | 5.83 | 5.09 | 6.22 | 7.41 | 7.37 |
| Quick Ratio | 4.29 | 4.29 | 3.44 | 3.49 | 2.91 | 3.39 | 3.76 | 3.41 | 4.47 | 5.57 | 5.33 |
| Cash Ratio | 1.02 | 1.02 | 2.15 | 1.91 | 1.30 | 2.07 | 2.50 | 2.08 | 3.04 | 4.16 | 3.60 |
| Asset Turnover | — | 0.77 | 0.78 | 0.68 | 0.62 | 0.60 | 0.68 | 0.82 | 0.86 | 0.70 | 0.85 |
| Inventory Turnover | 1.07 | 1.07 | 1.08 | 0.97 | 0.93 | 1.03 | 1.01 | 1.15 | 1.32 | 1.23 | 1.27 |
| Days Sales Outstanding | — | 49.41 | 51.23 | 69.57 | 87.63 | 65.39 | 74.64 | 70.61 | 67.18 | 63.44 | 60.07 |
PEN Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Penumbra, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 1.4% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 1.4% | 1.5% | 0.2% | 0.9% | — | 0.0% | — | 0.8% | 0.1% | 0.1% | 0.7% |
| FCF Yield | 1.4% | 1.4% | 1.6% | 0.8% | — | — | — | 0.1% | 0.4% | — | — |
| Buyback Yield | 0.0% | 0.0% | 1.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.4% | 0.0% | 0.1% |
| Total Shareholder Yield | 0.0% | 0.0% | 1.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.4% | 0.0% | 0.1% |
| Shares Outstanding | — | $39M | $39M | $39M | $38M | $38M | $36M | $36M | $36M | $35M | $33M |
Peer Comparison
Compare PEN with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 PENYou | $12B | 70.2 | 60.5 | 71.3 | 67.1% | 13.5% | 13.8% | 11.3% | 1.1 |
 ISRG | $144B | 51.7 | 39.0 | 58.0 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
 NVCR | $2B | -11.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 NVST | $4B | 92.5 | 13.8 | 18.3 | 55.0% | 8.3% | 1.6% | 4.8% | 5.0 |
 INVA | $2B | 6.8 | 6.8 | 8.5 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 SYK | $118B | 36.6 | 21.2 | 27.5 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 BSX | $67B | 23.3 | 20.8 | 18.4 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 MDT | $102B | 22.0 | 14.5 | 19.6 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 EW | $50B | 47.7 | 26.8 | 37.7 | 78.1% | 27.0% | 10.5% | 15.5% | 0.4 |
 ATRC | $1B | -120.0 | 80.7 | 30.2 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 |
 ZBH | $17B | 24.8 | 9.8 | 11.7 | 61.6% | 16.5% | 5.6% | 5.4% | 3.1 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 13 years · Updated daily
Consensus-Based Analysis Tools
Full Stock Analysis
Deep dive into PEN consensus models and risk factors.
View Analysis
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
PEN — Frequently Asked Questions
Quick answers to the most common questions about buying PEN stock.
What is Penumbra, Inc.'s P/E ratio?
Penumbra, Inc.'s current P/E ratio is 70.2x. The historical average is 111.2x. This places it at the 25th percentile of its historical range.
What is Penumbra, Inc.'s EV/EBITDA?
Penumbra, Inc.'s current EV/EBITDA is 60.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 78.9x.
What is Penumbra, Inc.'s ROE?
Penumbra, Inc.'s return on equity (ROE) is 13.8%. The historical average is 3.9%.
Is PEN stock overvalued?
Based on historical data, Penumbra, Inc. is trading at a P/E of 70.2x. This is at the 25th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Penumbra, Inc.'s profit margins?
Penumbra, Inc. has 67.1% gross margin and 13.5% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does Penumbra, Inc. have?
Penumbra, Inc.'s Debt/EBITDA ratio is 1.1x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.